II. Experimental section
Benzothiazole, KOtBu and DMSO were purchased commercially and used without further purification. Methoxy, methyl, and chloro-6-substitued benzothiazoles were prepared from 2-amino benzothiazoles. (1.5 mmol), KOtBu (1.0 mmol) and DMSO/H 2 O = 2 mL/0.5 mL. The reaction stirred at 100 o C for 8 h (monitored by TLC). Upon completion of the reaction, the mixture was diluted with H 2 O, extracted with dichloromethane (10 mL 3). The organic layers were combined and washed with brine, dried over MgSO 4 , filtered and concentrated. The crude product was purified with flash chromatography column on silica gel (gradient eluent of EtOAc in n-pentane: 1%, v/v) to yield the product as a colorless solid. This procedure was applied for the synthesis of 3a-3l.
Procedure for the synthesis of 3m. (i) A 25-mL round bottom flask was charged with 4-methyl-1,1'-biphenyl (1 mmol, 1 equiv), NBS (1.1 equiv), (PhCO 2 ) 2 (1 equiv) and CCl 4 (3 mL). The reaction was heated to reflux for 3 h Upon completion of the reaction, the mixture was diluted with H 2 O, extracted with dichloromethane (10 mL 3). The organic layers were combined and washed with brine, dried over MgSO 4 , filtered and concentrated. The crude product was purified with flash chromatography column to obtain the product 4-(bromomethyl)-1,1'-biphenyl in 88% yield. The product was used in the next step.
(ii) 4-(Bromomethyl)-1,1'-biphenyl was dissolved in Et 2 O (1 M), into this solution was added a solution of 50% aqueous dimethylamine solution (5 equiv) at room temperature. After stirring for 4-12 h at room temperature, the resulting mixture was transferred in separatory funnel. The organic phase was separated and the organic phase was extracted with 10 wt. % aqueous citric acid solution. The aqueous phases were treated with 15 wt. % aqueous sodium hydroxide solution. The mixture was extracted with ether and the combined organic extracts 
Characterization Data for Selected Compounds 2-phenylbenzothiazole (3a) 4
The product was isolated as a colorless solid, m.p. = 98. 
.
2-(2-fluorophenyl)benzothiazole (3b) 4
The product was isolated as a colorless solid in 39% yield (44 mg 4, 123.2, 124.6, 124.7, 125.3, 126.3, 129.7, 132 
2-(3-chlorophenyl)benzothiazole (3c) 4
The product was isolated as a colorless solid in 54% yield (65 mg 7, 123.4, 125.5, 125.6, 126.5, 127.3, 130.2, 130.8, 135.0, 135.1, 135.2, 153.9, 166.2 
; MS (m/z) 245 (M +
2-(4-Methylphenyl) benzothiazole (3d) 4
The product was isolated as a colorless solid in 62% yield (70 mg 
2-(2-methoxyphenyl)benzothiazole (3e) 4
The product was isolated as a colorless solid in 68% yield (81 mg 
2-(4-chlorophenyl)-6-methoxybenzothiazole (3f) 5
The product was isolated as a colorless solid in 55% yield (76 mg 
5-methoxy-2-(p-tolyl)benzothiazole (3g) 4
The product was isolated as a colorless solid in 66% yield (83 mg 
6-methoxy-2-(2-methoxyphenyl)benzothiazole (3h) 5
The product was isolated as a colorless solid in 71% yield (97 mg 6, 55.7, 103.4, 111.6, 115.4, 121.1, 122.4, 123.3, 129.2, 131.3, 137.5, 146.8, 156.9, 157.3, 160.7 ; HRMS (EI) m/z calcd. for C 15 H 13 NO 2 S: 271.0667, found 271.0670.
6-methoxy-2-phenylbenzothiazole (3i) 6
The product was isolated as a colorless solid in 68% yield (81 mg 48 (s, 3H), 7.29 (d, J = 8.0 Hz, 1H), 3H), 7.67 (s, 1H), 7.95 (d, J = 8.4 Hz, 1H 5, 121.3, 122.7, 127.4 (2C), 127.9, 128.9 (2C), 130.7, 133.7, 135.2, 135.3, 152.2, 167.0; MS (m/z) 225 (M   +   ) .
2-(4-chlorophenyl)-6-methylbenzothiazole (3k) 4
The product was isolated as a yellow solid in 57% yield (73 mg 111. 2, 118.5, 121.7, 123.3, 125.4, 126.4, 127.9 (2C), 128.1, 129.4 (2C), 130.0, 133.0, 133.9, 135.2, 140.5, 144.3, 154.1, 167 
